Harry Alcorn
Chief Medical Officer
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
DiaMedica Therapeutics Inc. (DMAC)
Source not stated
Start not stated–2022-05-23
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | DiaMedica Therapeutics Inc. (DMAC) | Jr., Pharm.D.^^ Senior Vice President of Clinical Operations | $302,112 | $545,268 |
| 2020 | DiaMedica Therapeutics Inc. (DMAC) | Jr., Pharm.D.^^ Senior Vice President of Clinical Operations | $291,413 | $509,065 |
| 2019 | DiaMedica Therapeutics Inc. (DMAC) | Jr., Pharm.D.^^ Chief Medical Officer | $273,750 | $778,300 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.